Komori
Statutory disclosure document4572Carna Biosciences,Inc.Pharmaceuticals

Confirmation of Reporting on the Transfer of Shares Issued through a Third-Party Allotment (New Shares)

kaya holdings株式会社 has undertaken to report any transfer during the 2 years after acquisition and cooperate with confirmation of the ownership status of the 366,400 new shares it will acquire from Carna Biosciences,Inc. through a third-party allotment.

Worth reading
63In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
366400
Shares
Wording
Definitive
How definitive the wording is.

Decision and Details

Confirmation of Reporting on the Transfer of Shares Issued through a Third-Party Allotment (New Shares)

Decision14 October 2026 (date of execution)
Period Covered2 years from 14 October 2026
Implementation14 October 2026 scheduled allotment (planned)
Going forwardIf Party A transfers the shares, Party B will immediately report the details of the transfer to the TSE in writing. Party B will submit a copy of this undertaking to the TSE immediately after its execution.
Quantity / scale366,400 Party B shares
Reason

Based on Article 422 of the Tokyo Stock Exchange Listing Regulations and Part II, Chapter 4, Section 2, Subsection 2 of the Enforcement Rules

Decision and Details
ItemDetails
Matter CoveredConfirmation of Reporting on the Transfer of Shares Issued through a Third-Party Allotment (New Shares)
Decision Date14 October 2026 (date of execution)
Implementation Date14 October 2026 scheduled allotment (planned)
Period Covered2 years from 14 October 2026
Quantity / scale366,400 Party B shares
ReasonBased on Article 422 of the Tokyo Stock Exchange Listing Regulations and Part II, Chapter 4, Section 2, Subsection 2 of the Enforcement Rules
Governing RuleArticle 422 of the Tokyo Stock Exchange Listing Regulations; Part 2, Chapter 4, Section 2, Subsection 2 of the Enforcement Rules
Future plansIf Party A transfers the shares, Party B will immediately report the details of the transfer to the TSE in writing. Party B will submit a copy of this undertaking to the TSE immediately after its execution.
Items this document does not state (4)
Decision-Making BodyAmountImpact on Business PerformanceRelated previous disclosures

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

This undertaking is based on the Tokyo Stock Exchange Listing Regulations and Enforcement Rules.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Confirmation of Reporting on the Transfer of Shares Issued through a Third-Party Allotment (New Shares) | Carna Biosciences,Inc. (4572) timely disclosure | Komori